
Duke Heme Onc Fellows Twitter Account! @dukecancer
Durham, NC
Joined April 2020
- Tweets91
- Following167
- Followers343
- Likes183
Duke HemeOnc Fellows retweeted
Our recent work led by @LandonBrownMD published today in @CCR_AACR showing clinical prognostic utility of a CTC genomic instability and NEPC phenotype in men with mCRPC urldefense.com/v3/__http://c…$ @DukeGUCancer @Daniel_J_George @EpicSciences @EAntonarakis
Duke HemeOnc Fellows retweeted
Happy first March Friday! An academic day - looking forward to @dukemedicine #grandrounds with Dr. @AmyOxentenkoMD on social media & reputation building at noon! medicine.duke.edu/medicinene… @IMResidencyDuke @DukeFellows @kcooney1234 @Daniel_J_George
Duke HemeOnc Fellows retweeted
Learn how to develop a rigorous research project and get it funded via the @CRTP_DukeSOM Research Project & Proposal Development course this fall!
Duke HemeOnc Fellows retweeted
Our review of #COVID19 vaccines and what they mean for our patients w/ cancer is published, led by @_joycehwang & w/ @andyzwang @Zihai! mRNA, adenovirus, protein, DNA vaccines - mechanisms & thoughts on when patients w/ cancer should receive them. jhoonline.biomedcentral.com/…
Duke HemeOnc Fellows retweeted
Join us as NIH's Drs. Kay Lund and Shoshana Kahana discuss NIH Support for Early Career Development, Wednesday February 24 @ 4pm. Register to receive Zoom URL at ow.ly/UMn850DyTqd
Duke HemeOnc Fellows retweeted
Excited to present the phase 2 PICK study led by @AarmstrongDuke at #GU21 Poster 89 - avelumab in neuroendocrine and agg variant #PCa
ORR 7% (1/15) - one CR in a pt with MSI-H
Limited efficacy of ICI alone in this aggressive dz
Future trials to consider chemo+dual ICI
📣Great learning opportunity!
Its been a wonderful experience organizing this conference with @DukeCancer @DukeCancerNETWK. Please join us March 20, Saturday for a virtual day of immune mediated toxicities. Register👉🏼bit.ly/Immunotox21 @TiansterZhang @CheckpointNowMD
We love this gem in our community! ♥️
Wondering what to expect from our Love and Lemurs video valentine? Check out these stills from one of our filming sessions!
Order the full video at lemur.duke.edu/valentine.
Solid work @LandonBrownMD ! 🙌
Replying to @ASCO
@ASCO #GU21 is imminently here!
Would like to highlight a few @DukeCancer projects being presented this week & any of our faculty or @DukeFellows @DukeUroRes trainees involved with these and add to the 🧵 as data are released.
📣Today is our Annual Hem/Onc Fellows Research Retreat!!! 🧬🔬 Can’t wait to hear our fellows showcase their incredible work!!! @DukeU @DukeCancer @DukeOPSD @DukeHMCT @DukeGUCancer
🤩😃🤩
Duke HemeOnc Fellows retweeted
At 5:30 PM (ET), the @DukeChapel bells will toll 40 times — once for every 10,000 American lives lost to COVID-19
An online presentation of tonight’s memorial is available on duke.edu
Duke HemeOnc Fellows retweeted
Register now for the free Jan. 25 #SITCGuidelines #webinar on #lymphoma, featuring Drs. Stephen Ansell (@MayoCancerCare), Michael Bishop @mrbishop_UC_BMT (@UChicago) and Sattva Neelapu (@md AndersonNews)! Register at sitcancer.org/LymphomaWebina…
📣Research week coming soon! 🥳🧬 🔬
Duke Research Week starts January 25th!
Don't miss out on Featured Panel Discussions, Faculty Lectures & Student Research Presentations! Register here: ow.ly/PM5n50D6ozX
Duke HemeOnc Fellows retweeted
Proud to recognize these outstanding Duke scientists included in @CellMentor’s list of 1,000 inspiring Black scientists! bit.ly/2K4jEMk
📣Fellows! Check out this great @ASCO_pubs opportunity!!
Wonderful opportunity for Oncology Fellows (current and within 1 year out of training)
The 2021 @ASCO @ASCO_pubs Editorial Fellowship
Can indicate interest (JCO, practice, global, precision, informatics)
1 page application
Feb 15, 2021 deadline
ascopubs.org/fellowship
This looks fun!!
📢Announcement #MedTwitter #OncTwitter
➡️We are excited to launch our online tumor board
💥Welcome to @TumorBoardTues💥
🗓️ Every 2 weeks, starting Tuesday Jan 12, 2021
➡️Just before #GI21
📱We will present a case for discussion and feedback tagging #TumorBoardTuesday
Duke HemeOnc Fellows retweeted
From #ACPJournalClub:
In cancer-related VTE, #DOACs reduce recurrent VTE compared with LMWH; groups do not differ for major bleeding ow.ly/RvpN50CMqAH. @McMasterU @ACPinternists



































